華北製藥(600812.SH)籌劃發行股份購買資產事項 明起停牌
格隆匯4月2日丨華北製藥(600812.SH)公佈,公司收到控股股東冀中能源集團通知,擬籌劃與公司有關的資產重組事項。公司擬通過發行股份及支付現金方式購買公司股東華北製藥集團有限責任公司(冀中能源集團全資子公司,以下簡稱“交易對方”或“華藥集團”)所持有的華北製藥集團愛諾有限公司(以下簡稱“愛諾公司”)51%股權(截至本公告日,公司持有愛諾公司剩餘49%股權)、華北製藥集團動物保健品有限責任公司(以下簡稱“動保公司”)100%股權及華藥集團持有的華北牌系列商標資產。同時,公司擬非公開發行股份募集配套資金。公司股票(證券簡稱:華北製藥,證券代碼:600812)自2020年4月3日開市起停牌,停牌時間不超過10個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.